Abivax (ABVX) Interest Expenses (2024 - 2026)
Abivax's (ABVX) quarterly Interest Expenses came in at -$5.6 million in Q1 2026, up 21.05% year-on-year from -$4.6 million in Q1 2025, and down 751.95% quarter-over-quarter from -$655356.5 in Q4 2025.
Abivax (ABVX) Interest Expenses (2024 - 2026) Analysis & Trends
Abivax's Interest Expenses history runs 3 years deep, the most recent figure standing at -$5.6 million for Q1 2026.
- On a quarterly basis, Interest Expenses rose 21.05% year-over-year to -$5.6 million in Q1 2026; TTM through Mar 2026 was -$121.1 million, a 137258.66% decrease from a year earlier, with the FY2025 full-year figure at $130.1 million, up 607.31% from the prior year.
- Interest Expenses slipped to -$5.6 million in Q1 2026 per ABVX's latest filing, from -$655356.5 in the prior quarter.
- Across five years, Interest Expenses topped out at $23.9 million in Q4 2024 and bottomed at -$108.8 million in Q3 2025.
- The 3-year median for Interest Expenses is -$6.1 million (2025), against an average of -$14.0 million.
- Across the five-year window, Interest Expenses slumped 1068.9% in 2025 and advanced 21.05% in 2026, its largest moves.
- Year by year, Interest Expenses stood at $23.9 million in 2024, then sank by 102.74% to -$655356.5 in 2025, then sank by 751.95% to -$5.6 million in 2026.
- Per Business Quant, the three latest ABVX Interest Expenses figures stand at -$5.6 million (Q1 2026), -$655356.5 (Q4 2025), and -$108.8 million (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -42,141.15 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 100,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 32.89 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 420.30 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 28.30 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 1.17 Bn |
| 10 | Abivax | 9.98 Bn | 9.98 Bn | - | -5.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.58 Mn |
| Mar 31, 2026 | -5.58 Mn |
| Dec 31, 2025 | -655,356.50 |
| Dec 31, 2025 | -655,356.50 |
| Sep 30, 2025 | -108.78 Mn |
| Sep 30, 2025 | -108.78 Mn |
| Jun 30, 2025 | -6.13 Mn |
| Jun 30, 2025 | -6.13 Mn |
| Mar 31, 2025 | -7.07 Mn |
| Mar 31, 2025 | -7.07 Mn |
| Dec 31, 2024 | 23.89 Mn |
| Dec 31, 2024 | 23.89 Mn |
| Sep 30, 2024 | -9.31 Mn |
| Sep 30, 2024 | -9.31 Mn |
| Jun 30, 2024 | -7.60 Mn |
| Jun 30, 2024 | -7.60 Mn |
| Mar 31, 2024 | -4.59 Mn |
| Mar 31, 2024 | -4.59 Mn |